NDC 0173-0913 – Blenrep

Belantamab Mafodotin 50 mg/mL · Injection, Powder, For Solution · Intravenous

Human Prescription Drug

Product NDC0173-0913

Product details

Brand name
Blenrep
Generic name
Belantamab mafodotin
Labeler
GlaxoSmithKline LLC
Dosage form
Injection, Powder, For Solution
Route
Intravenous
Marketing category
BLA · BLA761440
Marketed since
October 23, 2025
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Blenrep →

Package NDC codes (1)

Package NDCDescriptionSince
0173-0913-011 VIAL in 1 CARTON (0173-0913-01) / 1.4 mL in 1 VIALOct 23, 2025